MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Long-term effects of bilateral STN-DBS on speech in Parkinson’s disease patients

    F. Cavallieri, A. Gessani, V. Fioravanti, B. Damiano, S. Scaltriti, E. Bardi, M. Corni, F. Antonelli, V. Rispoli, G. Di Rauso, F. Cavalleri, M. Molinari, S. Contardi, E. Menozzi, S. Meletti, G. Biagini, E. Moro, A. Merlo, I. Campanini, C. Budriesi, F. Valzania (Reggio Emilia, Italy)

    Objective: To evaluate the long-term effects of bilateral STN-DBS on speech in advanced Parkinson’s disease (PD) patients. Background: Bilateral STN-DBS is an effective treatment in…
  • 2022 International Congress

    All that is gold does not glitter: SPG11 mimicking Westphal variant of Huntington’s disease

    A. Baltasar Corral, V. Gómez Mayordomo, A. García Ron, E. López Valdés, R. García-Ramos García (Madrid, Spain)

    Objective: Our objective was to bring light into infrequent causes of gait disorders in children mimicking well-known diseases, specifically with relevant family background. Background: Hereditary…
  • 2022 International Congress

    A precompetitive consortium approach to designing a qualitative study to generate content validity evidence to support the use of digital health technologies among people with early Parkinson’s disease

    R. Speck, J. Mammen, P. Yang, S. Jensen-Roberts, M. Kostrzebski, R. Dorsey, M. Müller, J. Cosman, J. Hellsten, J. Crawford, G. Stebbins, J. Cedarbaum, T. Simuni, T. Dam, K. Ward Barowicz, D. Stephenson, J. Adams (Tucson, USA)

    Objective: To understand from the patient perspective the relevance and comprehensiveness of the performance outcome (PerfO) measures administered via digital health technologies (DHTs) in the…
  • 2022 International Congress

    Therapies, Research Funding and Racial Diversity in Cerebellar Ataxia: A Systematic Review of the Literature

    C. Kingsbury, S. Ghanekar, Y. Huang, T. Ashizawa, S. Kuo, C. Gooch, T. Zesiewicz (Tampa, USA)

    Objective: To understand the scope of clinical research in cerebellar ataxia by performing a systematic review of controlled clinical trials over the past 50 years,…
  • 2022 International Congress

    Assessment of the long-term effects of STN-DBS on axial symptoms in PD patients through a standardized clinical-instrumental approach

    F. Cavallieri, I. Campanini, A. Gessani, V. Fioravanti, B. Damiano, S. Scaltriti, E. Bardi, M. Corni, F. Antonelli, V. Rispoli, G. Di Rauso, F. Cavalleri, M. Molinari, S. Contardi, E. Menozzi, S. Meletti, G. Biagini, E. Moro, C. Budriesi, A. Merlo, F. Valzania (Reggio Emilia, Italy)

    Objective: To evaluate the long-term effects of bilateral STN-DBS and levodopa on axial symptoms in PD patients and the possible correlations between speech and gait…
  • 2022 International Congress

    Dyskinesia profiles after dose challenges with L-dopa vs L-dopa plus ropinirole: a pilot study

    S. Grigoriou, P. Odin, E. Espa, A. Cenci (Lund, Sweden)

    Objective: To investigate possible differences in the profiles of abnormal involuntary movements (AIMs) in patients with Parkinson’s disease (PD) after dose challenge with L-dopa alone…
  • 2022 International Congress

    A role of β2-adrenoreceptor agonist related to the development of Parkinson’s disease

    WW. Lee (Seoul, Republic of Korea)

    Objective: To explore β2AR agonist’s effect on PD development with controlling for smoking. Background: Several studies have suggested the potential protective role of β2-adrenoreceptor agonist (β2AR…
  • 2022 International Congress

    Impaired Imagery of Tremor in Patients with Essential Tremor

    K. Steidel, A R. Abou Watfa, C. Nelles, E. Pelzer, M. Tittgemeyer, L. Timmermann, DJ. Pedrosa (Marburg, Germany)

    Objective: To investigate neural mechanisms underlying motor imagination (MI) in essential tremor (ET) patients compared to healthy controls using high-density EEG. Background: ET ranges among…
  • 2022 International Congress

    Differential temporal dynamics of axial and appendicular ataxia in SCA3

    R. Maas, S. Teerenstra, M. Lima, P. Pires, L. Pereira, J. van Gaalen, D. Timmann, J. Infante, C. Onyike, K. Bushara, H. Jacobi, K. Reetz, M. Santana, J. Ribeiro, J. Hübener-Schmid, J. de Vries, M. Synofzik, L. Schöls, H. Garcia-Moreno, P. Giunti, J. Faber, T. Klockgether, B. Vande Warrenburg (Nijmegen, Netherlands)

    Objective: To investigate the temporal dynamics of Scale for the Assessment and Rating of Ataxia (SARA) item scores in patients with spinocerebellar ataxia type 3…
  • 2022 International Congress

    Case reports of first experiences worldwide with novel continuous oral levodopa dental pump in Parkinson’s Disease Patients

    D. Mcintyre, O. Terwindt, L. Pavelka, G. Schilling, A. Znati, L. Skhiri, M. Gantenbein, E. Heller, A. Heller, J. Kennedy, J. Harmon, C. Kamp, M. Torti, CW. Olanow, R. Krueger (Strassen, Luxembourg)

    Objective: To assess the safety, tolerability, and pharmacokinetics (PK) of a novel continuous levodopa-carbidopa oral pump (LCOP) delivery system in patients with early PD. Background:…
  • « Previous Page
  • 1
  • …
  • 602
  • 603
  • 604
  • 605
  • 606
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley